Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease patent foramen ovale
Symptom C0038454|stroke
Sentences 65
PubMedID- 22933229 Closure or medical therapy for cryptogenic stroke with patent foramen ovale.
PubMedID- 24987042 patent foramen ovale (pfo) is associated with cryptogenic stroke, but uncertainty remains about the exact relationship and the best management.
PubMedID- 21794121 Background: despite the diffusion into practice of percutaneous closure of a patent foramen ovale (pfo) in patients with cryptogenic stroke (cs), the benefits have not been demonstrated, and remain unclear.
PubMedID- 24300230 A systematic review of closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and cryptogenic stroke or transient ischemic attack.
PubMedID- 24477152 Ischaemic stroke with patent foramen ovale.
PubMedID- 24739592 Differential lesion patterns on t2-weighted magnetic resonance imaging and fluid-attenuated inversion recovery sequences in cryptogenic stroke patients with patent foramen ovale.
PubMedID- 22263185 Of the remaining cases, one each was caused by right atrial thrombosis, patent foramen ovale (pfo) with cerebral stroke (for which we performed thromboembolectomy with pfo primary closure) and steroid taking due to renal failure.
PubMedID- 24495982 Risk of stroke in patients with patent foramen ovale: an updated meta-analysis of observational studies.
PubMedID- 20884416 Aims: though the association of patent foramen ovale with cryptogenic stroke in young patients has been known for 20 years, most interventional closure systems are not specifically designed for pfo closure, but instead are adapted from asd closure systems.
PubMedID- 23306323 Letter by furlan regarding "critique of closure or medical therapy for cryptogenic stroke with patent foramen ovale: the hole truth.
PubMedID- 24139929 Background: the optimal strategy for secondary prevention of cryptogenic stroke with a patent foramen ovale is unclear.
PubMedID- 23412553 Endothelial dysfunction is an independent risk factor for stroke patients irrespective of the presence of patent foramen ovale.
PubMedID- 24938843 Several studies have suggested that the deep lower extremity and pelvic veins might be an embolic source in cryptogenic stroke (cs) patients with patent foramen ovale.
PubMedID- 25248812 Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale.
PubMedID- 22867980 Thrombus through a patent foramen ovale: a direct cause of cardioembolic stroke and pulmonary embolism.
PubMedID- 21494544 Should patent foramen ovale be closed in patients with recent cryptogenic stroke or presumptive platypnea-orthodeoxia syndrome.
PubMedID- 24035325 Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale.
PubMedID- 20854974 patent foramen ovale (pfo) is associated with cryptogenic stroke, migraine headache, decompression sickness, and platypnea-orthodeoxia syndrome.
PubMedID- 26346232 Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
PubMedID- 23077982 Cardioembolic stroke in patients with patent foramen ovale and implanted cardiac leads.
PubMedID- 21190569 Several studies identified an increased frequency of patent foramen ovale (pfo) in patients with stroke of undetermined aetiology, also referred to as cryptogenic stroke (cs) .
PubMedID- 21356042 Background: several studies have shown an association of cryptogenic stroke and embolism with patent foramen ovale (pfo), but the question how to prevent further events in such patients is unresolved.
PubMedID- 23339957 Neuroimaging findings in cryptogenic stroke patients with and without patent foramen ovale.
PubMedID- 22845816 Aspirin is recommended in stroke patients with a patent foramen ovale and indications of closure should be individualized.
PubMedID- 22694009 Device closure for stroke with patent foramen ovale.
PubMedID- 25282541 Conclusion: our data suggest that acute pulmonary embolism resulting in right ventricular dysfunction may lead to acute ischemic stroke in patients with patent foramen ovale.
PubMedID- 26448826 We reported the patient who had multiple thrombi which were accompanied with a cryptogenic ischemic stroke and associated with patent foramen ovale after operation.
PubMedID- 21804775 Finally, we need to consider the possibility that patent foramen ovale discovered in patients with cryptogenic stroke might be incidental as has been argued to be the case by kent d. et al.
PubMedID- 20938409 Recurrence of cryptogenic stroke or tia in patients with patent foramen ovale successfully treated by using different kind of percutaneous occluder devices: five-year follow-up.
PubMedID- 22706547 Embolic stroke in a patient with a patent foramen ovale and an indwelling catheter.
PubMedID- 23451348 Response to letter regarding article, "critique of closure or medical therapy for cryptogenic stroke with patent foramen ovale: the hole truth.
PubMedID- 26486714 patent foramen ovale causing stroke in an elderly woman.
PubMedID- 21871067 Background: as previously reported there is evidence for a reduction in right to left shunt (rls) in stroke patients with patent foramen ovale (pfo).
PubMedID- 21789269 Whether or not the presence of a patent foramen ovale alone is associated with an increased stroke risk in pregnancy has not been properly examined, nor has the incidence of pregnancy-related stroke in association with peripartum cardiomyopathy.
PubMedID- 22417252 Background: the prevalence of patent foramen ovale among patients with cryptogenic stroke is higher than that in the general population.
PubMedID- 23117318 Background: the role of percutaneous closure of patent foramen ovale (pfo) in patients with cryptogenic stroke or transient ischemic attack remains controversial.
PubMedID- 24214884 Background: patent foramen ovale (pfo) is associated with cryptogenic stroke (cs), although the pathogenicity of a discovered pfo in the setting of cs is typically unclear.
PubMedID- 23908069 Closure put the brakes on indiscriminate device closure of patent foramen ovales in patients with cryptogenic stroke or transient ischemic attack.
PubMedID- 24582173 Purpose: to compare magnetic resonance imaging (mri) brain feature in cryptogenic stroke patients with patent foramen ovale (pfo), cryptogenic stroke patients without pfo and patients with cardioembolic stroke.
PubMedID- 22422892 Objective: to identify whether factors supporting a diagnosis of paradoxical embolism (i.e., venous thrombosis or valsalva maneuver) are associated with radiologic markers of recurrent strokes in patients with patent foramen ovale (pfo) and cryptogenic stroke (cs).
PubMedID- 23715857 Management of the stroke patient with patent foramen ovale: new insights and persistent questions in the wake of recent randomized trials.
PubMedID- 25994249 D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale.
PubMedID- 22180252 We synthesized the available evidence on secondary stroke prevention in patients with patent foramen ovale and cryptogenic stroke.
PubMedID- 21331344 They also recommended that cryptogenic stroke patients with patent foramen ovale should be investigated for deep venous thrombosis in the legs and pelvic veins.
PubMedID- 25358696 Provoked right-to-left shunt in patent foramen ovale associates with ischemic stroke in posterior circulation.
PubMedID- 22989503 Critique of closure or medical therapy for cryptogenic stroke with patent foramen ovale: the hole truth.
PubMedID- 23323125 A case of cryptogenic stroke associated with patent foramen ovale coexisting with pulmonary embolisms, deep vein thromboses, and renal artery infarctions.
PubMedID- 22348793 Methods: this is a cohort study on the effect of a standardised treatment of stroke patients with a patent foramen ovale.
PubMedID- 20446943 Prevention of stroke in patients with patent foramen ovale.
PubMedID- 24495944 Amplatzer pfo occluder device may prevent recurrent stroke in patients with patent foramen ovale and cryptogenic stroke: a meta-analysis of randomised trials.

Page: 1 2